Variant report

Variant	nsv879507
Chromosome Location	chr4:80365765-80552199
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:672)
CpG islands
(count:61)
Chromatin interactive
region (count:10)
LncRNA
region (count:18)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:672 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:80496141-80496176	K562	blood:	n/a	n/a
2	ARID3A	chr4:80497589-80497889	K562	blood:	n/a	n/a
3	ARID3A	chr4:80497603-80497843	HepG2	liver:	n/a	n/a
4	ARID3A	chr4:80541823-80542117	K562	blood:	n/a	n/a
5	ATF1	chr4:80497516-80497891	K562	blood:	n/a	n/a
6	ATF1	chr4:80524904-80525261	K562	blood:	n/a	n/a
7	ATF1	chr4:80484457-80484657	K562	blood:	n/a	n/a
8	ATF1	chr4:80541811-80542045	K562	blood:	n/a	n/a
9	ATF1	chr4:80435285-80435719	K562	blood:	n/a	n/a
10	BACH1	chr4:80418339-80418346	H1-hESC	embryonic stem cell:	n/a	n/a
11	BCL11A	chr4:80473623-80473792	H1-hESC	embryonic stem cell:	n/a	n/a
12	BCL3	chr4:80497562-80497841	GM12878	blood:	n/a	n/a
13	BHLHE40	chr4:80532222-80532519	K562	blood:	n/a	n/a
14	BHLHE40	chr4:80413202-80413295	K562	blood:	n/a	n/a
15	BHLHE40	chr4:80497515-80497874	K562	blood:	n/a	n/a
16	BHLHE40	chr4:80544430-80544470	K562	blood:	n/a	n/a
17	BHLHE40	chr4:80496417-80496439	K562	blood:	n/a	n/a
18	BHLHE40	chr4:80449536-80449542	K562	blood:	n/a	n/a
19	BRCA1	chr4:80497726-80497750	HepG2	liver:	n/a	n/a
20	CCNT2	chr4:80525875-80526041	K562	blood:	n/a	n/a
21	CCNT2	chr4:80541582-80542094	K562	blood:	n/a	n/a
22	CCNT2	chr4:80551624-80551778	K562	blood:	n/a	n/a
23	CEBPB	chr4:80541810-80542102	K562	blood:	n/a	chr4:80541937-80541950
24	CEBPB	chr4:80433017-80433352	HepG2	liver:	n/a	chr4:80433186-80433197 chr4:80433184-80433195
25	CEBPB	chr4:80368404-80368611	A549	lung:	n/a	chr4:80368461-80368472 chr4:80368461-80368474
26	CEBPB	chr4:80377571-80377876	HepG2	liver:	n/a	chr4:80377723-80377734
27	CEBPB	chr4:80496222-80496357	HepG2	liver:	n/a	n/a
28	CEBPB	chr4:80384870-80385070	HepG2	liver:	n/a	chr4:80384916-80384927
29	CEBPB	chr4:80494907-80495145	HepG2	liver:	n/a	chr4:80495054-80495065 chr4:80495053-80495066
30	CEBPB	chr4:80541793-80542107	K562	blood:	n/a	chr4:80541937-80541950
31	CEBPB	chr4:80516663-80516889	HepG2	liver:	n/a	chr4:80516800-80516813
32	CEBPB	chr4:80516675-80516894	K562	blood:	n/a	chr4:80516800-80516813
33	CEBPB	chr4:80419551-80419874	HepG2	liver:	n/a	n/a
34	CEBPB	chr4:80387471-80387474	H1-hESC	embryonic stem cell:	n/a	n/a
35	CEBPB	chr4:80368456-80368543	HepG2	liver:	n/a	chr4:80368461-80368472 chr4:80368461-80368474
36	CEBPB	chr4:80446198-80446286	HepG2	liver:	n/a	n/a
37	CEBPB	chr4:80496035-80496510	K562	blood:	n/a	n/a
38	CEBPB	chr4:80367856-80368008	K562	blood:	n/a	chr4:80367941-80367954 chr4:80367943-80367952 chr4:80367942-80367953 chr4:80367941-80367952
39	CEBPB	chr4:80532233-80532506	K562	blood:	n/a	n/a
40	CEBPB	chr4:80507006-80507341	H1-hESC	embryonic stem cell:	n/a	n/a
41	CEBPB	chr4:80433072-80433327	IMR90	lung:	n/a	chr4:80433186-80433197 chr4:80433184-80433195
42	CEBPB	chr4:80462261-80462309	K562	blood:	n/a	n/a
43	CEBPB	chr4:80433060-80433324	K562	blood:	n/a	chr4:80433186-80433197 chr4:80433184-80433195
44	CEBPB	chr4:80518436-80518635	HepG2	liver:	n/a	chr4:80518476-80518489
45	CEBPB	chr4:80473430-80473771	H1-hESC	embryonic stem cell:	n/a	n/a
46	CEBPB	chr4:80367837-80368113	HepG2	liver:	n/a	chr4:80367941-80367954 chr4:80367943-80367952 chr4:80367942-80367953 chr4:80367941-80367952 chr4:80367840-80367851
47	CEBPB	chr4:80387366-80387574	K562	blood:	n/a	n/a
48	CEBPB	chr4:80373464-80373664	HepG2	liver:	n/a	chr4:80373590-80373601
49	CEBPB	chr4:80494897-80495230	K562	blood:	n/a	chr4:80495054-80495065 chr4:80495053-80495066
50	CEBPB	chr4:80494975-80495224	IMR90	lung:	n/a	chr4:80495054-80495065 chr4:80495053-80495066

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:80413489-80413539	SK-N-MC	brain:	n/a
2	chr4:80413489-80413539	HCPEpiC	choroid plexus:	n/a
3	chr4:80413489-80413539	A549	lung:	n/a
4	chr4:80413489-80413539	GM12892	blood:	n/a
5	chr4:80413489-80413539	AG09319	gingival:	n/a
6	chr4:80413489-80413539	PFSK-1	brain:	n/a
7	chr4:80413489-80413539	HIPEpiC	eye:	n/a
8	chr4:80413489-80413539	NHBE	bronchial:	n/a
9	chr4:80413489-80413539	AG04450	lung:	fetal
10	chr4:80413489-80413539	ECC-1	luminal epithelium:	n/a
11	chr4:80413489-80413539	Jurkat	blood:	n/a
12	chr4:80413489-80413539	LNCaP	prostate:	n/a
13	chr4:80413489-80413539	RPTEC	kidney:	n/a
14	chr4:80413489-80413539	MCF-7	breast:	n/a
15	chr4:80413489-80413539	GM06990	blood:	n/a
16	chr4:80413489-80413539	HCT-116	colon:	n/a
17	chr4:80413489-80413539	BE2_C	brain:	n/a
18	chr4:80413489-80413539	ProgFib	skin:	n/a
19	chr4:80413489-80413539	HepG2	liver:	n/a
20	chr4:80413489-80413539	NH-A	brain:	n/a
21	chr4:80413489-80413539	NT2-D1	testis:	n/a
22	chr4:80413489-80413539	HPAEpiC	pulmonary alveolar:	n/a
23	chr4:80413489-80413539	HRCEpiC	kidney:	n/a
24	chr4:80413489-80413539	AG10803	skin:	n/a
25	chr4:80413489-80413539	HCF	heart:	n/a
26	chr4:80413489-80413539	AG09309	skin:	n/a
27	chr4:80413489-80413539	HEEpiC	esophagus:	n/a
28	chr4:80413489-80413539	CMK	blood:	n/a
29	chr4:80413489-80413539	Hela-S3	cervix:	n/a
30	chr4:80413489-80413539	PANC-1	pancreas:	n/a
31	chr4:80413489-80413539	Hepatocyte	liver:	n/a
32	chr4:80413489-80413539	SK-N-SH_RA	brain:	n/a
33	chr4:80413489-80413539	HNPCEpiC	eye:	n/a
34	chr4:80413489-80413539	AG04449	skin:	fetal
35	chr4:80413489-80413539	HCM	heart:	n/a
36	chr4:80413489-80413539	HL-60	blood:	n/a
37	chr4:80413489-80413539	HEK293	kidney:	embryo
38	chr4:80413489-80413539	HAEpiC	amniotic membrane:	n/a
39	chr4:80413489-80413539	U87	brain:	n/a
40	chr4:80413489-80413539	SK-N-SH	brain:	n/a
41	chr4:80413489-80413539	MCF10A-Er-Src	breast:	n/a
42	chr4:80413489-80413539	IMR90	lung:	fetal
43	chr4:80413489-80413539	AoSMC	blood vessel:	n/a
44	chr4:80413489-80413539	SAEC	small airway:	n/a
45	chr4:80413489-80413539	NHDF-neo	bronchial:	n/a
46	chr4:80413489-80413539	HMEC	breast:	n/a
47	chr4:80413489-80413539	NB4	blood:	n/a
48	chr4:80413489-80413539	HUVEC	blood vessel:	n/a
49	chr4:80413489-80413539	ovcar-3	ovarian:	n/a
50	chr4:80413489-80413539	HRPEpiC	eye:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:80163067..80163617-chr4:80497361..80497863,2	MCF-7	breast:
2	chr4:80162158..80162658-chr4:80497305..80497853,2	MCF-7	breast:
3	chr17:59884431..59885001-chr4:80544092..80544675,2	MCF-7	breast:
4	chr4:79963329..79963907-chr4:80497328..80498247,2	K562	blood:
5	chr4:80509176..80511123-chr4:80514677..80516383,2	K562	blood:
6	chr4:80281030..80283740-chr4:80487916..80490045,2	K562	blood:
7	chr4:80241849..80242382-chr4:80497698..80498294,2	MCF-7	breast:
8	chr4:79963311..79963867-chr4:80497354..80497886,2	MCF-7	breast:
9	chr4:80516564..80518189-chr4:80518557..80520658,2	K562	blood:
10	chr4:79964140..79964963-chr4:80497048..80497852,2	MCF-7	breast:

(count:18 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-BMP2K-3	chr4:80414306-80414739	ENSG00000250334
2	lnc-BMP2K-3	chr4:80414306-80414739	NONHSAT097114
3	lnc-BMP2K-1	chr4:80446864-80446906	l_2674_chr4:80088967-80336103_prostate
4	lnc-BMP2K-3	chr4:80413570-80413777	ENSG00000250334
5	lnc-BMP2K-3	chr4:80496295-80497614	ENSG00000250334
6	lnc-BMP2K-3	chr4:80496295-80497612	ENSG00000250334
7	lnc-BMP2K-3	chr4:80434939-80435056	ENSG00000250334
8	lnc-PRDM8-3	chr4:80518031-80518327	ENSG00000251399
9	lnc-BMP2K-3	chr4:80414306-80414739	ENSG00000250334
10	lnc-PRDM8-3	chr4:80517696-80517753	ENSG00000251399
11	lnc-BMP2K-3	chr4:80434939-80435056	ENSG00000250334
12	lnc-BMP2K-3	chr4:80413747-80413928	ENSG00000250334
13	lnc-PRDM8-9	chr4:80476639-80477031	NONHSAT097115
14	lnc-BMP2K-3	chr4:80434939-80435056	NONHSAT097114
15	lnc-BMP2K-3	chr4:80496295-80497614	NONHSAT097114
16	lnc-PRDM8-9	chr4:80472781-80474355	NONHSAT097115
17	lnc-BMP2K-1	chr4:80448451-80448970	l_2674_chr4:80088967-80336103_prostate
18	lnc-BMP2K-3	chr4:80413747-80413928	NONHSAT097114

No data

Variant related genes	Relation type
OR7E94P	TF binding region
LINC00989	TF binding region
ENSG00000251399	TF binding region
OR7E94P	CpG island
LINC00989	CpG island
ENSG00000251399	CpG island
ENSG00000251399	chromatin interactions
ENSG00000249646	chromatin interactions

Extended variants
information (count: 5253 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:5253 , 50 per page) page: 1 2 3 4 5 6 7 ... 106

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6838184	chr4:80365765-80365766	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs185230147	chr4:80365773-80365774	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs190079680	chr4:80365798-80365799	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs568810863	chr4:80365858-80365859	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs116305632	chr4:80365862-80365863	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs572394987	chr4:80365870-80365871	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs566339991	chr4:80365911-80365912	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs541301683	chr4:80365923-80365924	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs564309170	chr4:80365926-80365927	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs540125694	chr4:80365962-80365963	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs538148659	chr4:80366010-80366011	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs76576691	chr4:80366087-80366088	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs563228131	chr4:80366119-80366120	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs182132833	chr4:80366232-80366233	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs36041299	chr4:80366305-80366306	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs548704453	chr4:80366310-80366311	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs185869963	chr4:80366313-80366314	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs5859691	chr4:80366359-80366360	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs398107547	chr4:80366369-80366370	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs76986671	chr4:80366370-80366371	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs58146485	chr4:80366529-80366530	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs140946378	chr4:80366579-80366580	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs59441294	chr4:80366590-80366591	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs537242834	chr4:80366614-80366615	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs114369353	chr4:80366772-80366773	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs189421293	chr4:80366786-80366787	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs536725094	chr4:80366849-80366850	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs116833274	chr4:80366909-80366910	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs573261063	chr4:80366915-80366916	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs28690339	chr4:80366964-80366965	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs573409350	chr4:80366983-80366984	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs145099962	chr4:80366999-80367000	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs374721741	chr4:80367003-80367004	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs372376562	chr4:80367111-80367112	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs149122303	chr4:80367138-80367139	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs543263743	chr4:80367190-80367191	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs563451580	chr4:80367194-80367195	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs369072325	chr4:80367196-80367197	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs573675234	chr4:80367302-80367303	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs542670924	chr4:80367305-80367306	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs565281677	chr4:80367314-80367315	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs180989619	chr4:80367340-80367341	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs573818069	chr4:80367387-80367388	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs185216128	chr4:80367396-80367397	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs377302412	chr4:80367401-80367402	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs531067849	chr4:80367429-80367430	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs550895657	chr4:80367462-80367463	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs567815813	chr4:80367467-80367468	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs536383142	chr4:80367479-80367480	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs547052046	chr4:80367543-80367544	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Autism	18414403	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
primary effusion lymphomas	17116491	CNVD
Gastric cancer	16891809	CNVD
Prostate cancer	16573809	CNVD
Myelofibrosis	22110671	CNVD
Neuroblastoma	21899760	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Myelodysplastic syndrome	18508791	CNVD
Glioma	20126413	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Chronic lymphocytic leukemia	21215367	CNVD

Chromatin state (count:644 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:80364200-80365800	Weak transcription	NHDF-Ad	bronchial
2	chr4:80365800-80366800	Enhancers	NHDF-Ad	bronchial
3	chr4:80366200-80366800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr4:80366400-80366800	Enhancers	HUES6 Cell Line	embryonic stem cell
5	chr4:80366400-80366800	Enhancers	iPS-20b Cell Line	embryonic stem cell
6	chr4:80366400-80367000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
7	chr4:80366600-80367000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
8	chr4:80366600-80367000	Enhancers	Cortex derived primary cultured neurospheres	brain
9	chr4:80366600-80367000	Enhancers	Fetal Muscle Leg	muscle
10	chr4:80366600-80367400	Enhancers	ES-I3 Cell Line	embryonic stem cell
11	chr4:80366800-80367000	Flanking Active TSS	Aorta	Aorta
12	chr4:80366800-80367200	Enhancers	HUES64 Cell Line	embryonic stem cell
13	chr4:80366800-80367600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
14	chr4:80366800-80367600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
15	chr4:80366800-80368600	Weak transcription	HUES6 Cell Line	embryonic stem cell
16	chr4:80367200-80367600	Weak transcription	HUES64 Cell Line	embryonic stem cell
17	chr4:80367400-80367800	Enhancers	Pancreatic Islets	Pancreatic Islet
18	chr4:80367400-80368000	Enhancers	iPS-15b Cell Line	embryonic stem cell
19	chr4:80367600-80367800	Enhancers	HUES48 Cell Line	embryonic stem cell
20	chr4:80367600-80367800	Enhancers	HUES64 Cell Line	embryonic stem cell
21	chr4:80367600-80367800	Enhancers	iPS-20b Cell Line	embryonic stem cell
22	chr4:80367800-80368000	Enhancers	iPS-18 Cell Line	embryonic stem cell
23	chr4:80367800-80368000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
24	chr4:80367800-80371400	Weak transcription	HUES64 Cell Line	embryonic stem cell
25	chr4:80368000-80368400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
26	chr4:80368400-80368800	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr4:80368600-80368800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
28	chr4:80368600-80369000	Enhancers	H9 Cell Line	embryonic stem cell
29	chr4:80368600-80369000	Enhancers	HUES6 Cell Line	embryonic stem cell
30	chr4:80371400-80371800	Enhancers	HUES64 Cell Line	embryonic stem cell
31	chr4:80371800-80374400	Weak transcription	HUES64 Cell Line	embryonic stem cell
32	chr4:80374400-80374800	Enhancers	HUES64 Cell Line	embryonic stem cell
33	chr4:80374400-80375200	Enhancers	ES-I3 Cell Line	embryonic stem cell
34	chr4:80374400-80375200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr4:80374600-80375000	Enhancers	HUES48 Cell Line	embryonic stem cell
36	chr4:80374800-80375200	Enhancers	iPS-18 Cell Line	embryonic stem cell
37	chr4:80375000-80375400	Enhancers	iPS-20b Cell Line	embryonic stem cell
38	chr4:80375200-80385000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
39	chr4:80375800-80376800	Enhancers	Fetal Heart	heart
40	chr4:80381400-80381800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
41	chr4:80381400-80381800	Enhancers	Fetal Brain Female	brain
42	chr4:80381600-80382000	Enhancers	Cortex derived primary cultured neurospheres	brain
43	chr4:80381600-80382200	Enhancers	Brain Germinal Matrix	brain
44	chr4:80382800-80384000	Enhancers	Fetal Heart	heart
45	chr4:80383200-80383800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
46	chr4:80385000-80386800	Enhancers	ES-I3 Cell Line	embryonic stem cell
47	chr4:80385000-80386800	Enhancers	HUES6 Cell Line	embryonic stem cell
48	chr4:80385200-80385600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr4:80385200-80385600	Enhancers	Muscle Satellite Cultured Cells	--
50	chr4:80385400-80385600	Enhancers	NHDF-Ad	bronchial

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links